2023
Current State of Peer Learning in Radiology: A Survey of ACR Members
Sharpe R, Tarrant M, Brook O, Chatfield M, Chaudhry H, City R, Donnelly L, Goldberg-Stein S, Hernandez D, Hwang G, Kunst M, Lee R, Moriarity A, Pahade J, Patel S, Broder J. Current State of Peer Learning in Radiology: A Survey of ACR Members. Journal Of The American College Of Radiology 2023, 20: 699-711. PMID: 37230234, DOI: 10.1016/j.jacr.2023.03.018.Peer-Reviewed Original ResearchConceptsRoutine clinical practicePractice improvement projectACR membersClinical practicePractice characteristicsPatient careRadiology practiceHealth careImprovement initiativesImprovement projectTotal sampleCareRadiologistsACRCurrent practiceUrban settingsPL activityNet Promoter ScorePopulationImproved cultureIncidenceNonusers
2021
Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection?
Guo Y, Czeyda-Pommersheim F, Miccio JA, Mahalingam S, Cecchini M, Pahade J. Can a simplified CT response criteria for vascular involvement in pancreatic adenocarcinoma after neoadjuvant therapy predict survival in patients who achieved subsequent R0 resection? Abdominal Radiology 2021, 46: 5609-5617. PMID: 34557934, DOI: 10.1007/s00261-021-03284-5.Peer-Reviewed Original ResearchConceptsSubsequent R0 resectionOverall survivalR0 resectionNeoadjuvant therapyPancreatic ductal adenocarcinomaImaging responseMultivariable Cox proportional hazards analysisCox proportional hazards analysisPostoperative CA19-9Median overall survivalImproved diseaseProportional hazards analysisKaplan-Meier analysisSimilar diseasesPatient ageVascular involvementClinical stagingMethodsRetrospective analysisPredict SurvivalClinical parametersPDAC patientsCA 19CA19-9Mean ageCancer patients
2020
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer.
Cecchini M, Miccio JA, Pahade J, Lacy J, Salem RR, Johnson SB, Blakaj A, Stein S, Kortmansky JS, Johung KL. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Pancreas 2020, 49: 904-911. PMID: 32658074, DOI: 10.1097/mpa.0000000000001592.Peer-Reviewed Original ResearchConceptsPancreatic ductal adenocarcinomaLA PDACUnresectable pancreatic ductal adenocarcinomaInduction FOLFIRINOXConsolidative radiotherapyOverall survivalAdvanced unresectable pancreatic ductal adenocarcinomaSingle-center retrospective reviewMeaningful survival benefitMedian overall survivalUnresectable pancreatic cancerR0 resection rateKaplan-Meier methodSingle institution experienceBenefits of surgeryLog-rank testConsolidative radiationDefinitive radiationLA patientsPreoperative radiationResection rateSurgery patientsSurvival benefitSurvival impactImproved survival
2018
Benefit of a Visual Aid in the Management of Moderate-Severity Contrast Media Reactions.
Gardner JB, Rashid S, Staib L, Asch D, Cavallo J, Arango J, Kirsch J, Pahade J. Benefit of a Visual Aid in the Management of Moderate-Severity Contrast Media Reactions. American Journal Of Roentgenology 2018, 211: 717-723. PMID: 30106614, DOI: 10.2214/ajr.18.19689.Peer-Reviewed Original ResearchMRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
Sheridan AD, Nath SK, Aneja S, Syed JS, Pahade J, Mathur M, Sprenkle P, Weinreb JC, Spektor M. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI. American Journal Of Roentgenology 2018, 210: w218-w225. PMID: 29489409, DOI: 10.2214/ajr.17.18680.Peer-Reviewed Original ResearchConceptsPI-RADS 5 lesionsBenign pathologic resultsLower prostate-specific antigen densitySignificant prostate cancerProstate-specific antigen densityBenign prostatic hyperplasia nodulesMRI-ultrasound fusionProstate Imaging ReportingCategory 5 lesionsPathologic resultsProstate cancerClinical featuresBenign diseaseAntigen densityImaging ReportingGleason 6 diseasePI-RADS version 2High-risk lesionsMultivariate logistic regressionRoutine clinical interpretationMultiparametric prostate MRIInflammatory changesNormal anatomic structuresBiopsy resultsTargeted biopsiesWhat Patients Want to Know about Imaging Examinations: A Multiinstitutional U.S. Survey in Adult and Pediatric Teaching Hospitals on Patient Preferences for Receiving Information before Radiologic Examinations.
Pahade JK, Trout AT, Zhang B, Bhambhvani P, Muse VV, Delaney LR, Zucker EJ, Pandharipande PV, Brink JA, Goske MJ. What Patients Want to Know about Imaging Examinations: A Multiinstitutional U.S. Survey in Adult and Pediatric Teaching Hospitals on Patient Preferences for Receiving Information before Radiologic Examinations. Radiology 2018, 287: 554-562. PMID: 29436946, DOI: 10.1148/radiol.2017170592.Peer-Reviewed Original Research
2017
JOURNAL CLUB: Benefit of Epinephrine Autoinjector for Treatment of Contrast Reactions: Comparison of Errors, Administration Times, and Provider Preferences.
Asch D, Pfeifer KE, Arango J, Staib L, Cavallo J, Kirsch JD, Arici M, Pahade J. JOURNAL CLUB: Benefit of Epinephrine Autoinjector for Treatment of Contrast Reactions: Comparison of Errors, Administration Times, and Provider Preferences. American Journal Of Roentgenology 2017, 209: w363-w369. PMID: 28570127, DOI: 10.2214/ajr.16.17111.Peer-Reviewed Original Research
2016
Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
Pahade JK, Juice D, Staib L, Israel G, Cornfeld D, Mitchell K, Weinreb J. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies? Abdominal Radiology 2016, 41: 1270-1284. PMID: 26800701, DOI: 10.1007/s00261-016-0635-9.Peer-Reviewed Original Research
2015
High-Fidelity Contrast Reaction Simulation Training: Performance Comparison of Faculty, Fellows, and Residents
Pfeifer K, Staib L, Arango J, Kirsch J, Arici M, Kappus L, Pahade J. High-Fidelity Contrast Reaction Simulation Training: Performance Comparison of Faculty, Fellows, and Residents. Journal Of The American College Of Radiology 2015, 13: 81-87. PMID: 26549266, DOI: 10.1016/j.jacr.2015.08.016.Peer-Reviewed Original ResearchDelayed Growth in Incidental Pancreatic Cysts: Are the Current American College of Radiology Recommendations for Follow-up Appropriate?
Brook OR, Beddy P, Pahade J, Couto C, Brennan I, Patel P, Brook A, Pedrosa I. Delayed Growth in Incidental Pancreatic Cysts: Are the Current American College of Radiology Recommendations for Follow-up Appropriate? Radiology 2015, 278: 752-61. PMID: 26348231, DOI: 10.1148/radiol.2015140972.Peer-Reviewed Original ResearchConceptsIncidental pancreatic cystsCurrent American CollegePancreatic cystsAmerican CollegeRadiology recommendationsCyst sizeInstitutional review board-approved HIPAA-compliant retrospective studyIntraductal papillary mucinous neoplasmMedian cyst sizeMajority of patientsHIPAA-compliant retrospective studyHigh-grade dysplasiaPapillary mucinous neoplasmMagnetic resonance examinationMedian followCyst characteristicsMedian imagingPancreatic surgeryMucinous neoplasmsRetrospective studyPancreatic adenocarcinomaPatient levelCyst dimensionsKruskal-Wallis testPatients
2013
CT angiography in potential living kidney donors: 80 kVp versus 120 kVp.
Davarpanah AH, Pahade JK, Cornfeld D, Ghita M, Kulkarni S, Israel GM. CT angiography in potential living kidney donors: 80 kVp versus 120 kVp. American Journal Of Roentgenology 2013, 201: w753-60. PMID: 24147505, DOI: 10.2214/ajr.12.10439.Peer-Reviewed Original Research
2012
Reviewing imaging examination results with a radiologist immediately after study completion: patient preferences and assessment of feasibility in an academic department.
Pahade J, Couto C, Davis RB, Patel P, Siewert B, Rosen MP. Reviewing imaging examination results with a radiologist immediately after study completion: patient preferences and assessment of feasibility in an academic department. American Journal Of Roentgenology 2012, 199: 844-51. PMID: 22997377, PMCID: PMC3786865, DOI: 10.2214/ajr.11.8064.Peer-Reviewed Original ResearchConceptsDuration of consultationExamination findingsHearing resultsPatient preferencesUltrasound examinationOrdering providerExamination resultsMost patientsProspective surveyAbnormal resultsStudy completionNormal resultsImaging examinationsRadiology resultsPatientsAssessment of feasibilityAnxiety levelsRadiologistsAverage waitCTConsultationAverage wait timeExaminationWait timeCommunication of results
2011
Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT.
Pahade JK, LeBedis CA, Raptopoulos VD, Avigan DE, Yam CS, Kruskal JB, Pedrosa I. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. American Journal Of Roentgenology 2011, 196: 1094-101. PMID: 21512075, DOI: 10.2214/ajr.10.5152.Peer-Reviewed Original ResearchConceptsContrast-induced nephropathyContrast-enhanced CTDevelopment of CINAverage creatinine levelCreatinine levelsMicroglobulin levelsCECT examinationsMultiple myelomaCT examinationsBlood urea nitrogen-creatinine ratioIncidence of CINNormal creatinine levelsHistory of diabetesAssociated risk factorsBence Jones proteinuriaDiagnosis of myelomaHistory of myelomaContrast agentsAlbumin levelsRetrospective reviewPatient populationMedical recordsRisk factorsLower riskPatients
2008
Imaging of Malignant Skeletal Tumors
Pahade J, Sekhar A, Shetty SK. Imaging of Malignant Skeletal Tumors. Cancer Treatment And Research 2008, 143: 367-422. PMID: 18619226, DOI: 10.1007/978-0-387-75587-8_15.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingPositron emission tomographyClinical featuresMalignant skeletal tumorsCommon malignant lesionKey imaging characteristicsSecondary neoplasmsBone scintigraphyPrimary lesionFinal diagnosisMalignant entitiesHistologic diagnosisSkeletal tumorsDifferential diagnosisMalignant tumorsEvidence-based foundationMalignant lesionsLesionsResonance imagingEmission tomographyImaging characteristicsPotential imaging modalityDiagnosisImaging modalitiesRecent evidence